Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. - Bi WL; Nayak L; Meredith DM; Driver J; Du Z; Hoffman S; Li Y; Lee EQ; Beroukhim R; Rinne M; McFaline-Figueroa R; Chukwueke U; et al. (Neuro-oncology, 2022)